Home NDC 82972-001 QAMZOVA
Product NDC 82972-001
11-digit product format 829720001
Labeler code 82972
Product ID 82972-001_348c7a0b-c446-d540-e063-6394a90aa4d1
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Meloxicam
Dosage form INJECTION
Route INTRAVENOUS
Labeler Nanjing Delova Biotech Co., Ltd.
Application NDA217593
Marketing category NDA
Marketing start 2025-10-15
Substance MELOXICAM
Active strength 30 mg/mL
Pharmacologic classes Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217593-001 QAMZOVA MELOXICAM 30MG/ML (30MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2025-04-22
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217593-001 12059423 2040-07-19 Drug substance, Drug product 2025-04-23
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N217593-001 QAMZOVA 30MG/ML (30MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2025-04-22 84e616aacf4f…2026-08-18 06:07:40 2026-07 N217593-001 QAMZOVA 30MG/ML (30MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2025-04-22 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N217593-001 QAMZOVA 30MG/ML (30MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2025-04-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217593-001 QAMZOVA 30MG/ML (30MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2025-04-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217593-001 QAMZOVA 30MG/ML (30MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2025-04-22 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217593-001 QAMZOVA 30MG/ML (30MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2025-04-22 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N217593-001 12059423 2040-07-19 Drug substance, Drug product 2025-04-23 84e616aacf4f…2026-08-18 06:07:40 2026-07 N217593-001 12059423 2040-07-19 Drug substance, Drug product 2025-04-23 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N217593-001 12059423 2040-07-19 Drug substance, Drug product 2025-04-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217593-001 12059423 2040-07-19 Drug substance, Drug product 2025-04-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217593-001 12059423 2040-07-19 Drug substance, Drug product 2025-04-23 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217593-001 12059423 2040-07-19 Drug substance, Drug product 2025-04-23 a50c72e98297…
Additional Listing Data#
Finished product Yes
Brand name base QAMZOVA
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength MELOXICAM 30 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination VG2QF83CGL Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2281106 Internal RxNorm lookup 2727445 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 82972-001-30 QAMZOVA 1 in 1 CARTON INJECTION 1 2 82972-001-30 QAMZOVA 1 mL in 1 VIAL, SINGLE-DOSE INJECTION 1 2
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join QAMZOVA MELOXICAM Nanjing Delova Biotech Co., Ltd. 385fd779-1be1-49ae-8213-750b96ecc997 2026-07-16 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 217593 application number: NDA217593 ndc (product): 82972-001
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 82972-001-30 82972000130 1 VIAL, SINGLE-DOSE in 1 CARTON (82972-001-30) / 1 mL in 1 VIAL, SINGLE-DOSE 2025-10-15 No No Current